Genomma Lab Internacional SAB de CV Class B (GNMLF)
OTHER OTC:GNMLF
Total Valuation
Genomma Lab Internacional SAB de CV has a market cap or net worth of $886.77M. The enterprise value is $24.81B.
Market Cap$886.77M
Enterprise Value$24.81B
Share Statistics
Genomma Lab Internacional SAB de CV has 1,000,000,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,000,000,000
Owned by Insiders―
Owned by Institutions<0.01%
Financial Efficiency
Genomma Lab Internacional SAB de CV’s return on equity (ROE) is 0.14 and return on invested capital (ROIC) is 12.78%.
Return on Equity (ROE)0.14
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)12.78%
Return on Capital Employed (ROCE)0.23
Revenue Per Employee10.93M
Profits Per Employee1.00M
Employee Count1,605
Asset Turnover0.74
Inventory Turnover3.54
Valuation Ratios
The current PE Ratio of Genomma Lab Internacional SAB de CV is 8.9. Genomma Lab Internacional SAB de CV’s PEG ratio is ―.
PE Ratio8.9
PS Ratio0.00
PB Ratio0.00
Price to Fair Value1.57
Price to FCF0.00
Price to Operating Cash Flow10.78
PEG Ratio―
Income Statement
In the last 12 months, Genomma Lab Internacional SAB de CV had revenue of 17.54B and earned 1.61B in profits. Earnings per share was 1.65.
Revenue17.54B
Gross Profit11.02B
Operating Income3.76B
Pretax Income2.43B
Net Income1.61B
EBITDA3.61B
Earnings Per Share (EPS)1.65
Cash Flow
In the last 12 months, operating cash flow was 1.54B and capital expenditures -201.84M, giving a free cash flow of 1.33B billion.
Operating Cash Flow1.54B
Free Cash Flow1.33B
Free Cash Flow per Share1.33
Dividends & Yields
Genomma Lab Internacional SAB de CV pays an annual dividend of $0.011, resulting in a dividend yield of 4.48%
Dividend Per Share$0.011
Dividend Yield4.48%
Payout Ratio33.76%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.61
52-Week Price Change-21.12%
50-Day Moving Average0.97
200-Day Moving Average1.00
Relative Strength Index (RSI)36.66
Average Volume (3m)836.00
Important Dates
Genomma Lab Internacional SAB de CV upcoming earnings date is Jul 29, 2026, After Close (Confirmed).
Last Earnings DateApr 23, 2026
Next Earnings DateJul 29, 2026
Ex-Dividend Date―
Financial Position
Genomma Lab Internacional SAB de CV as a current ratio of 1.77, with Debt / Equity ratio of 40.36%
Current Ratio1.77
Quick Ratio1.52
Debt to Market Cap0.43
Net Debt to EBITDA1.33
Interest Coverage Ratio4.72
Taxes
In the past 12 months, Genomma Lab Internacional SAB de CV has paid 826.24M in taxes.
Income Tax826.24M
Effective Tax Rate0.34
Enterprise Valuation
Genomma Lab Internacional SAB de CV EV to EBITDA ratio is 6.16, with an EV/FCF ratio of 10.96.
EV to Sales1.27
EV to EBITDA6.16
EV to Free Cash Flow10.96
EV to Operating Cash Flow10.82
Balance Sheet
Genomma Lab Internacional SAB de CV has $2.81B in cash and marketable securities with $5.06B in debt, giving a net cash position of -$1.92B billion.
Cash & Marketable Securities$2.81B
Total Debt$5.06B
Net Cash-$1.92B
Net Cash Per Share-$1.92
Tangible Book Value Per Share$5.73
Margins
Gross margin is 62.71%, with operating margin of 21.43%, and net profit margin of 9.16%.
Gross Margin62.71%
Operating Margin21.43%
Pretax Margin13.87%
Net Profit Margin9.16%
EBITDA Margin20.58%
EBIT Margin18.42%
Analyst Forecast
The average price target for Genomma Lab Internacional SAB de CV is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-5.15%
EPS Growth Forecast-28.53%